ENTITY
Shanghai MicroPort MedBot

Shanghai MicroPort MedBot (2252 HK)

90
Analysis
Health Care • China
Shanghai MicroPort MedBot is a surgical robot company that designs, develops, manufactures, and commercializes surgical robots and associated digital surgical solutions. Its product portfolio covers surgical specialties including endoscopy, orthopedics, vascular intervention, natural orifice surgery, and percutaneous puncture, with key products like the Toumai laparoscopic surgical robot, DFVision 3D electronic laparoscope, and SkyWalker orthopedic surgical robot. The company is headquartered in Shanghai, China, and was officially established in 2015.
more
bullish•Quantitative Analysis
•29 Sep 2024 10:05

Hong Kong Connect Flows (Sep 26th): Alibaba, HKEx, Kuaishou Technology, Meituan, Tencent

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Alibaba, HKEx, Kuaishou Technology, Meituan, Tencent,...

Logo
451 Views
Share
bearish•UBTECH Robotics
•21 Dec 2023 15:05

UBTech Robotics IPO - Quick Thoughts on Valuation - Too Hefty a Premium for Slowing Growth

UBTech Robotics (9880 HK) is looking to raise about US$168m in its upcoming HK IPO, after downsizing from an earlier reported float of up to US$700m.

Logo
921 Views
Share
bearish•Doosan Robotics
•04 Oct 2023 15:15

Doosan Robotics IPO Trading - Strong Insti Subscription Rates but Still Feels like a Punt

Doosan Robotics (454910 KS) raised around US$318m in its Korea IPO, after pricing its IPO at the top end of the range at KRW26,000/share.

Logo
820 Views
Share
bearish•Doosan Robotics
•13 Sep 2023 09:00

Doosan Robotics IPO - Updated Thoughts on Valuation - Sentiments Going Out of Control

Doosan Robotics (454910 KS) is looking to raise up to US$318m in its Korean IPO. In this note, we share our updated thoughts on valuation.

Logo
832 Views
Share
•01 Jun 2023 09:10

Pre IPO MicroPort Cardiac Rhythm Management - The Industry, the Business and the Challenges Ahead

MicroPort CRM's' business layout mainly comes from the acquisition of LivaNova, but it's hard to achieve breakthrough in market share. The Company...

Logo
701 Views
Share
x